Showing results (11-20 of 165) with videos related to
Sort By:
Pageof 17
Cancer Letters|June 3, 2004
Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clustersMin-Kyoung Kim, Sabine Zitzmann, Frank Westermann, et al.Japanese Journal of Clinical Oncology|April 27, 2013
Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomasKiyoshi Asada, Naoko Watanabe, Yohko Nakamura, et al.European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.International Journal of Cancer|December 13, 2007
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cellsHedwig E Deubzer, Volker Ehemann, Frank Westermann, et al.Cancer Letters|June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaIsabella Eckerle, Daniel Muth, Julia Batzler, et al.Genes, Chromosomes & Cancer|June 29, 2006
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastomaQing-Rong Chen, Sven Bilke, Jun S Wei, et al.Pathology Oncology Research : POR|January 1, 1997
MYCN Amplification in Neuroblastoma: a Paradigm for the Clinical Use of an OncogeneManfred SchwabAnnals of the New York Academy of Sciences|July 4, 2002
Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncologyManfred SchwabCancer Letters|February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitroHedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.Pageof 17